Latency differences of lysosomal enzymes in cardiac and skeletal muscles of male and female mice

The purpose of this study was to compare the latencies of lysosomal enzymes (beta-glucuronidase, beta-N-acetylglucosaminidase, arylsulphatase and acid ribonuclease) in heart and in red and white skeletal muscle of male and female mice (Mus musculus). The unsedimentable, free activities together with releasable (Triton X-100, hypotonic shock and freeze-thawing treatments) and unreleasable, bound activities were assayed. The distribution of acid hydrolases to different fractions was strikingly heterogeneous. The most distinct differences occurred between the distributions of beta-glucuronidase and beta-N-acetylglucosaminidase. The differences between muscle types occurred in the activity levels of lysosomal enzymes, rather than in the fractional distributions. Sex-related differences were small and occurred mainly in the activity levels of heart muscle (higher in female mice). The results suggest that the heterogeneous distribution of lysosomal enzymes originates in the compartmental differences of lysosomal enzymes in muscle cells, rather than the differences in cell populations of different muscle types.     

Calcium-related defects in cardiac and skeletal muscles of dystrophic mice

Ca2+ ATPase and calcium binding proteins were studied in cardiac and skeletal muscles of normal and dystrophic mice. In normal and dystrophic mice, Ca2+ ATPase was quite reduced in cardiac muscle compared to skeletal muscle and was, unlike skeletal muscle, insensitive to orthovanadate. Ca2+ ATPase in skeletal muscle of dystrophic mice was reduced as compared to normal mice. In both cases (normal and dystrophic), calcium binding proteins were the same (identical molecular weight). The effect of 2 drugs (Polymixine B and Bepridil) which decrease protein bound calcium was studied: the muscle proteins of dystrophic mice did not present the same sensitivity to Bepridil as controls. These findings suggest the existence of a calcium-related defect in skeletal and cardiac muscle of dystrophic mice.     

Retarded myogenic cell replication in regenerating skeletal muscles of old mice: an autoradiographic study in young and old BALBc and SJL/J mice

The patterns of skeletal muscle precursor cell replication after crush injury were compared by the use of autoradiographic techniques, in young (4-week-old) and old (39-week-old) BALBc and SJL/J mice. Similar comparisons were made between cut and crush lesions in old BALBc muscle. Muscle precursor cell replication commenced at 18–24 h after injury in both young and old muscles from both strains of mice. In young BALBc muscle the peak of myogenic activity at 60 h was 36 h earlier than in old mice. SJL/J muscle responded more rapidly than did BALBc: in young SJL/J the peak myogenic activity was at 46 h (14 h earlier than in young BALBc muscle), and in old SJL/J muscle the peak activity at 72 h was 24 h earlier than in old BALBc muscle. In all mice (both young and old) myogenic cell replication was substantially reduced by 120 h after injury. A comparison of the timing of muscle precursor cell replication in cut and crush lesions in old BALBc mice revealed a more rapid response in the cut lesion: this difference between the lesions in comparable with data from identical lesion in 6-8-week-old BALBc mice (McGeachie and Grounds 1987). However, the peak of myogenic replication in the older mice in the present study was some 26–36 h later than in the younger 6-8-week-old mice. These experiments show that, whilst muscle precursor cell replication commences at approximately the same time (about 24 h) after injury in young and old mice, the peak level of activity is delayed by some 24–36 h in old mice. In addition, the SJL/J mouse strain responds more rapidly and prolifically to muscle injury than does the BALBc strain.     

Genetic determinants of weight of fast- and slow-twitch skeletal muscles in old mice

The main goal of the study was to explore the genetic architecture underlying muscle weight in old mice. Weight of soleus, tibialis anterior (TA), extensor digitorum longus (EDL), and gastrocnemius muscles was measured in the C57BL/6J (B6) and DBA/2J (D2) strains and derivative generations: a panel of the BXD recombinant inbred (RI) strains and a B6D2 F₂ intercross at the age of 800 days. The between-strain difference in muscle weight (B6 > D2) ranged between 16% and 38%. Linkage analysis identified suggestive quantitative trait loci (QTL) on Chromosomes (Chr) 2, 6, 7, 8, 19, and X that influenced muscle weight in the 800-day-old group. Comparison of weights at 200, 500, and 800 days revealed a variable effect of age among the four muscles. Linkage analysis in the B6D2 F₂ population combined across the three different age groups identified muscle-, sex-, and age-specific QTL on Chr 1, 2, 3, 5, 6, 8, 9, 11, 13, 17, X, and Y. Genetic factors that influence the rate of weight change (within-strain weight difference at two ages) over the lifespan of BXD RIs were mapped to the markers D2Mit369 and D3Mit130 at the genome-wide p < 0.05 for TA muscle in males (between 200 and 800 days) and females (between 500 and 800 days), respectively. Analysis of all age groups supported previous findings that the genetic effects may be muscle-, age-, and sex-specific.     

Negamycin restores dystrophin expression in skeletal and cardiac muscles of mdx mice

The ability of aminoglycoside antibiotics to promote read-through of nonsense mutations has attracted interest in these drugs as potential therapeutic agents in genetic diseases. However, the toxicity of aminoglycoside antibiotics may result in severe side effects during long-term treatment. In this paper, we report that negamycin, a dipeptide antibiotic, also restores dystrophin expression in skeletal and cardiac muscles of the mdx mouse, an animal model of Duchenne muscular dystrophy (DMD) with a nonsense mutation in the dystrophin gene, and in cultured mdx myotubes. Dystrophin expression was confirmed by immunohistochemistry and immunoblotting. We also compared the toxicity of negamycin and gentamicin, and found negamycin to be less toxic. Furthermore, we demonstrate that negamycin binds to a partial sequence of the eukaryotic rRNA-decoding A-site. We conclude that negamycin is a promising new therapeutic candidate for DMD and other genetic diseases caused by nonsense mutations.     

Effect of microgravity on the expression of mitochondrial enzymes in rat cardiac and skeletal muscles

Connor, Michael K., and David A. Hood. Effect ofmicrogravity on the expression of mitochondrial enzymes in rat cardiac and skeletal muscles. J. Appl.Physiol. 84(2): 593-598, 1998.The purpose ofthis study was to examine the expression of nuclear and mitochondrialgenes in cardiac and skeletal muscle (triceps brachii) in response toshort-duration microgravity exposure. Six adult male rats were exposedto microgravity for 6 days and were compared with six ground-basedcontrol animals. We observed a significant 32% increase in heartmalate dehydrogenase (MDH) enzyme activity, which was accompanied by a62% elevation in heart MDH mRNA levels after microgravity exposure.Despite modest elevations in the mRNAs encoding subunits III, IV, andVIc as well as a 2.2-fold higher subunit IV protein content afterexposure to microgravity, heart cytochromec oxidase (CytOx) enzyme activityremained unchanged. In skeletal muscle, MDH expression was unaffectedby microgravity, but CytOx activity was significantly reduced 41% bymicrogravity, whereas subunit III, IV, and VIc mRNA levels and subunitIV protein levels were unaltered. Thus tissue-specific (i.e., heart vs.skeletal muscle) differences exist in the regulation of nuclear-encoded mitochondrial proteins in response to microgravity. In addition, theexpression of nuclear-encoded proteins such as CytOx subunit IV andexpression of MDH are differentially regulated within a tissue. Ourdata also illustrate that the heart undergoes previously unidentifiedmitochondrial adaptations in response to short-term microgravityconditions more dramatic than those evident in skeletal muscle. Furtherstudies evaluating the functional consequences of these adaptations inthe heart, as well as those designed to measure protein turnover, arewarranted in response to microgravity.

     

Activity of phosphorylcreatine shuttle enzymes in rat cardiac, fast-, and slow-twitch skeletal muscles

Energy producing and energy utilizing reactions in muscle are coherently linked by a phosphorylcreatine shuttle mechanism. Operational components of the shuttle were evaluated in muscles encompassing a wide metabolic and contractile spectrum. Consistent CPK/ATPase ratios suggest homogeneous function of the myofibrillar component of the shuttle. Mitochondrial CPK/ATPase ratios vary due to 4-fold differences in CPK activity with respect to oxidative phosphorylation. The phosphorylcreatine shuttle mechanism, and the mitochondrial component in particular, seems a relevant, physiological regulator of skeletal and cardiac muscle function.     

Localization of talin in skeletal and cardiac muscles

Antibodies to talin and vinculin were used for localization of these proteins in skeletal and cardiac muscles by the indirect immunofluorescence method. We have found that talin is localized in intercalated discs of cardiac muscle and in costameres of skeletal and cardiac muscles. It is suggested that in striated muscles talin and vinculin play an important role in interactions between actin filaments and membranes.     

Content and synthesis of several abundant glycolytic enzymes in skeletal muscles of normal and dystrophic mice

• 1.1. In both 2- and 3-month-old 129 ReJ mice, the catalytic activity levels of three enzymes involved in glycogen breakdown (phosphorylase, enolase, and aldolase) were found to be 35–50% lower in hind limb muscles of dystrophic mice as compared with normal mice.
• 2.2. The reduced activities of these enzymes in the diseased tissue was directly due to corresponcling reductions in the number of enzyme molecules rather than being due to inactivation of the enzymes in the dystrophic muscle.
• 3.3. Results of short term double isotope incorporation experiments conducted with muscle expiants in vitro suggested that the rates of synthesis of these enzymes, and of most other abundant cytosolic proteins, relative to each other, were similar in hind limb muscles of normal and dystrophic mice.
• 4.4. The present work on murine muscular dystrophy is discussed in terms of our previous studies into the influence of avian muscular dystrophy on the content and synthesis of abundant glycolytic enzymes in chicken skeletal muscles.

     

Ruthenium-red staining of skeletal and cardiac muscles

Summary The effects of ruthenium red (RR) on amphibian and mammalian skeletal muscles and mammalian myocardium were examined. In skeletal muscle cells, a discrete pattern of staining can be brought about within the lumina of the terminal cisternae (junctional sarcoplasmic reticulum [SR]) by sequential exposure to RR and OsO₄. After prolonged immersion in RR solution, formation of pentalaminar segments (zippering) occurs at various points along the longitudinal (network) SR tubules. Zippering can be elicited in skeletal SR at any stage of preparation prior to postfixation with OsO₄. By means of dispersive X-ray analysis, both ruthenium and osmium were seen to be deposited in skeletal muscle junctional SR, and ruthenium was detected in the myoplasm as well. In skeletal muscles whose T tubules were ruptured by exposure to glycerol, the pattern of SR staining and zippering resulting from ruthenium-osmium treatment was not affected. These findings indicate that RR is capable of passage across the sarcolemma of skeletal muscle and that this passage does not occur solely under conditions in which the plasma membrane is damaged. In contrast, RR does not opacify or modify any region of the SR of cardiac muscle. However, after this treatment, randomly distributed opaque bodies, composed of parallel lamellar structures, appear throughout the myocardial cells. A few of these bodies are associated with lipid droplets, but the rest are of unknown origin. The failure of the SR of cardiac muscle to stain after exposure to ruthenium dye (even though this material enters these cells) suggests that the chemical composition of cardiac SR is significantly different from that of skeletal muscle SR.Supported in part by PHS grant HL-11155 (to N.S.) and American Heart Grant-in-Aid 78-753 (to M.S.F.). The authors are grateful to Drs. David Harder and Lawrence Sellin for their assistance with the preparation of frog skeletal muscle, to Dr. S.K. Jirge for his helpful suggestions and discussions, and particularly to Dr. Kenneth R. Lawless and Ms. Ann Marshall of the Department of Materials Sciences, University of Virginia School of Engineering, and Col. John M. Brady of the United States Army Institute of Dental Research, Walter Reed Army Medical Center, for their help with, and for the use of, the X-ray analysis equipment     

Developmental changes of cardiac and slow skeletal muscle troponin T expression in chicken cardiac and skeletal muscles

Numerous troponin T (TnT) isoforms are produced by alternative splicing from three genes characteristic of cardiac, fast skeletal, and slow skeletal muscles. Apart from the developmental transition of fast skeletal muscle TnT isoforms, switching of TnT expression during muscle development is poorly understood. In this study, we investigated precisely and comprehensively developmental changes in chicken cardiac and slow skeletal muscle TnT isoforms by two-dimensional gel electrophoresis and immunoblotting with specific antisera. Four major isoforms composed of two each of higher and lower molecular weights were found in cardiac TnT (cTnT). Expression of cTnT changed from high- to low-molecular-weight isoforms during cardiac muscle development. On the other hand, such a transition was not found and only high-molecular-weight isoforms were expressed in the early stages of chicken skeletal muscle development. Two major and three minor isoforms of slow skeletal muscle TnT (sTnT), three of which were newly found in this study, were expressed in chicken skeletal muscles. The major sTnT isoforms were commonly detected throughout development in slow and mixed skeletal muscles, and at developmental stages until hatching-out in fast skeletal muscles. The expression of minor sTnT isoforms varied from muscle to muscle and during development.     

Alterations of the Z-band in cardiac and skeletal muscles.

The heart muscle may react to various hypoxic damaging effects (e.g.N2, CO, haemorrhagic shock, electroshock) by identical responses similarly as in the case of skeletal muscle damages. One of the early manifestations of the process is the alteration of the Z-band, which is considered pathological. The alterations of the Z-band region precede the changes of the mitochondrial and sacrotubular systems and might form the morphological basis of functional changes induced by hypoxic effects. The alterations observed are differentiated from the hypertrophy of the Z-band. In the development of the alterations of the Z-band the role of other factors (e.g. calcium metabolism, sacroplasmatic membrane changes) is emphasized.     

Functional implications of RyR-dHPR relationships in skeletal and cardiac muscles

Dihydropyridine receptors (DHPRs) and ryanodine receptors (RyRs) interact during EC coupling within calcium release units, CRUs. The location of the two channels and their positioning are related to their role in EC coupling. alphals DHPR and RyR1 of skeletal muscle form interlocked arrays. Groups of four DHPRs (forming a tetrad) are located on alternate RyR1s. This association provides the structural framework for reciprocal signaling between the two channels. RyR3 are present in some skeletal muscles in association with RyR1 and in ratios up to 1:1. RyR3 neither induce formation of tetrads by DHPRs nor sustain EC coupling. RyR3 are located in a parajunctional position, in proximity of the RyR1-DHPR complexes, and they may be indirectly activated by calcium liberated via the RyR1 channels. RyR2 have two locations in cardiac muscle. One is at CRUs that contain DHPRs and RyRs. In these cardiac CRUs, RyR2 and alpha1c DHPR are in proximity of each other, but not closely linked, so that they may not have a direct molecular interaction. A second location of RyR2 is on SR cisternae that are not attached to surface membrane/T tubules. The RyR2 in these cisternae, which are often several microns away from any DHPRs, must necessarily be activated indirectly.